From August 15th, Chengdu officially launched a pilot project for free DNA prenatal screening for pregnant women with a peripheral blood fetus

In order to ensure the implementation of the "three -child" fertility policy, reduce the burden on the birth of the masses, strengthen the prevention and control of birth defects, and continue to optimize the fertility service measures, in accordance with the requirements of the Sichuan Provincial Health and Health Commission on the pilot work of prenatal screening and diagnosis of pregnant women's peripherals of pregnant women On August 15, 2022, Chengdu officially launched a pilot project (hereinafter referred to as the "NIPT") pilot project (hereinafter referred to as the "NIPT") pilot project.

NIPT uses pregnant women's peripheral blood as a detection specimen, and uses high -throughput sequencing technology to detect the dNA fragment during the peripheral blood of the maternal peripheral blood during pregnancy. Combined with biological information analysis, the method of calculating the common chromosomal risk of fetal sufferings in the fetus. The target disease of the screening is 21-tritenom syndrome (that is, Tang's syndrome), 18-trisomy syndrome, and 13-trio syndrome. Slowly development, low language and behavioral ability, and can be accompanied by severe death deformed.

The NIPT pilot project follows the implementation principles of "informed notification, voluntary selection, and managed according to law". Any pregnant woman who has established a health care file in the 23 districts (cities) and counties in Chengdu City, from August 15, 2022, August 15, 2022 Starting in the middle of pregnancy, prenatal scheme screening (Tang's screening), and meets one of the following conditions, you can enjoy the free NIPT detection of the secondary pregnancy: First, the Tang family screening in the middle of pregnancy prompts a critical risk person; The second is that Tang's screening in the middle of pregnancy suggests high risk, but pregnant women who have contraindications before the diagnosis of amniotic fluid puncture.

The NIPT pilot project is an important measure to benefit the people after the implementation of newborn genetic metabolic diseases, hearing impairment, congenital heart disease, and deaf gene free screening items. The launch of the pilot project will further improve the comprehensive prevention and control network of birth defects in our city, which will play a positive role in reducing the incidence of major birth defects, improving the level of eugenics and the quality of birth, and promoting the construction of healthy Chengdu.

Chengdu Daily Jinguan Journalist Wang Jingyu Source Health Chengdu Official WeChat Editor He Qixie Editor Liu Yonghao

- END -